Free Trial

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.47 +0.02 (+0.19%)
As of 07/24/2025 10:07 AM Eastern

OACC vs. ORC, FBRT, NXRT, PAX, NOAH, AC, GETY, AACT, PLYM, and TINV

Should you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Orchid Island Capital (ORC), Franklin BSP Realty Trust (FBRT), NexPoint Residential Trust (NXRT), Patria Investments (PAX), Noah (NOAH), Associated Capital Group (AC), Getty Images (GETY), Ares Acquisition Corporation II (AACT), Plymouth Industrial REIT (PLYM), and Tiga Acquisition (TINV). These companies are all part of the "trading" industry.

Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Orchid Island Capital (NYSE:ORC) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Orchid Island Capital
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Orchid Island Capital had 5 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 6 mentions for Orchid Island Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Orchid Island Capital's score of 0.34 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Orchid Island Capital Neutral

Orchid Island Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Orchid Island Capital$52.24M17.67$37.66M$0.4018.21

Orchid Island Capital's return on equity of 1.52% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Orchid Island Capital N/A 1.52%0.17%

32.7% of Orchid Island Capital shares are owned by institutional investors. 0.4% of Orchid Island Capital shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Orchid Island Capital beats Oaktree Acquisition Corp. III Life Sciences on 7 of the 8 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

MetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$234.74M$166.94M$6.42B$9.52B
Dividend YieldN/AN/A4.19%3.99%
P/E RatioN/AN/A14.0720.01
Price / SalesN/AN/A1,734.40102.39
Price / CashN/A36,857.63128.7058.97
Price / BookN/AN/A1.965.87
Net IncomeN/A-$160K$1.24B$258.50M
7 Day Performance0.38%0.45%0.39%1.95%
1 Month Performance-0.19%0.93%3.62%12.31%
1 Year PerformanceN/A6.02%23.68%19.02%

Oaktree Acquisition Corp. III Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.47
+0.2%
N/AN/A$234.74MN/A0.00N/APositive News
ORC
Orchid Island Capital
3.1199 of 5 stars
$7.06
-0.3%
N/A-11.7%$897.15M$241.58M17.652,018News Coverage
Earnings Report
FBRT
Franklin BSP Realty Trust
3.9507 of 5 stars
$10.47
-2.2%
$15.13
+44.5%
-23.0%$880.52M$210.45M15.40N/APositive News
Upcoming Earnings
NXRT
NexPoint Residential Trust
4.8637 of 5 stars
$34.00
-0.9%
$43.58
+28.2%
-21.0%$867.28M$255.34M-26.563Upcoming Earnings
PAX
Patria Investments
2.8045 of 5 stars
$13.87
-0.1%
$14.00
+0.9%
+7.6%$841.09M$390.10M27.74390News Coverage
High Trading Volume
NOAH
Noah
3.4742 of 5 stars
$12.23
+1.2%
$12.00
-1.9%
+65.0%$799.97M$2.57B12.611,990Positive News
AC
Associated Capital Group
2.2559 of 5 stars
$37.52
+0.0%
N/A+13.0%$792.89M$12.29M20.9620
GETY
Getty Images
2.6906 of 5 stars
$1.73
-0.9%
$4.35
+152.2%
-47.6%$719.35M$939.29M-9.081,700
AACT
Ares Acquisition Corporation II
N/A$11.38
flat
N/A+6.4%$703.96MN/A0.00N/A
PLYM
Plymouth Industrial REIT
3.802 of 5 stars
$15.46
+0.5%
$21.10
+36.5%
-34.9%$700.98M$198.35M5.0740Positive News
TINV
Tiga Acquisition
N/A$19.94
-5.9%
N/A+69.1%$687.93MN/A0.00N/AHigh Trading Volume

Related Companies and Tools


This page (NASDAQ:OACC) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners